SCHEMBL809458

SCHEMBL809458

O=C1c2ccccc2C(=O)N1Sc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
MC4R P32245 1/20 0.44
EHMT2 Q96KQ7 1/20 0.42
EHMT1 Q9H9B1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30872008 1.00 CASP3 (0.48) CASP3NPC1RAB9ASMN1; SMN2SENP8
SCHEMBL11105056 0.85 KMT2A (0.46) CASP3NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL20503165 0.85 MEN1 (0.52) CASP3NPC1RAB9AMAPTALDH1A1
SCHEMBL28673975 0.84 GSK3B (0.44) CASP3NPC1RAB9ASMN1; SMN2SENP8
SCHEMBL5372576 0.84 MEN1 (0.53) RAB9AMAPTALDH1A1HSD17B10PKM
SCHEMBL29727795 0.84 MAP2K7 (0.41) CASP3NPC1RAB9ASMN1; SMN2SENP8
SCHEMBL29727850 0.79 MMP2 (0.43) CASP3MAPTALDH1A1HSD17B10PKM
SCHEMBL29475759 0.79 RAB9A (0.50) CASP3NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL16694595 0.79 RAB9A (0.50) CASP3NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL11286851 0.77 RAB9A (0.38) CASP3NPC1RAB9ASMN1; SMN2SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260051516-A1 LITHIUM PRIMARY BATTERY PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2026-02-19 US claimed
US-12492220-B2 Method for the preparation of oligonucleotides THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2025-12-09 US claimed
EP-4622463-A1 SYNERGISTIC INSECTICIDAL COMPOSITION COMPRISING PHTHALIMIDE COMPOUNDS AND THE USE THEREOF Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) (IN) 2025-10-01 EP claimed
EP-4579775-A1 LITHIUM PRIMARY BATTERY Panasonic Intellectual Property Management Co., Ltd. (JP) 2025-07-02 EP claimed
EP-4579776-A1 LITHIUM PRIMARY BATTERY Panasonic Intellectual Property Management Co., Ltd. (JP) 2025-07-02 EP claimed
EP-4579777-A1 LITHIUM PRIMARY BATTERY Panasonic Intellectual Property Management Co., Ltd. (JP) 2025-07-02 EP claimed
US-20250192192-A1 LITHIUM PRIMARY BATTERY PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-06-12 US claimed
CN-119731792-A Lithium primary battery 松下知识产权经营株式会社 2025-03-28 CN claimed
CN-119731793-A Lithium primary battery 松下知识产权经营株式会社 2025-03-28 CN claimed
CN-119698698-A Lithium primary battery 松下知识产权经营株式会社 2025-03-25 CN claimed
CN-111727973-B Application of N- (phenylthio) phthalimide in reducing wheat toxin content 江苏丘陵地区镇江农业科学研究所 2021-06-04 CN claimed
CN-110590624-B Preparation method of lipoic acid derivative 8- (ethyl disulfide) -6- (phenyl disulfide) caprylic acid 苏州富士莱医药股份有限公司 2021-02-26 CN claimed
CN-111727973-A Application of N- (phenylthio) phthalimide in reducing wheat toxin content 江苏丘陵地区镇江农业科学研究所 2020-10-02 CN claimed
CN-110590624-A Preparation method of lipoic acid derivative 8- (ethyldisulfanyl) -6- (phenyldisulfanyl) octanoic acid 苏州富士莱医药股份有限公司 2019-12-20 CN claimed
CN-108299677-A A kind of new type rubber antiscorching agent and its preparation process 山东阳谷华泰化工股份有限公司 2018-07-20 CN claimed
EP-3318546-A1 PROCESS FOR THE CHLORINATION AND IODINATION OF COMPOUNDS USING N-HYDROXYPHTHALIMIDE Justus-Liebig-Universität Gießen (DE) 2018-05-09 EP claimed
US-7871746-B2 Thiophthalimides containing photoconductors XEROX CORPORATION (US) 2011-01-18 US claimed
US-20090274971-A1 THIOPHTHALIMIDES CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-11-05 US claimed
EP-0014997-B1 4-ARYLOXY- AND 4-ARYLTHIO-3-PHENYLPIPERIDINE DERIVATIVES, A PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1983-07-20 EP claimed
EP-0014997-A1 4-Aryloxy- and 4-arylthio-3-phenylpiperidine derivatives, a process for the preparation of such compounds and pharmaceutical compositions containing them HOECHST AKTIENGESELLSCHAFT (DE) 1980-09-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260051516-A1 LITHIUM PRIMARY BATTERY SLC5A11, RPL13, INCENP CASP3 4164/4885NPC1 2236/4885RAB9A 802/4885
US-12492220-B2 Method for the preparation of oligonucleotides POLN, POLRMT, POLI CASP3 3961/4885NPC1 4293/4885RAB9A 4612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.